Clinical Trial Update: S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated gemcitabine plus cisplatin for unresectable malignant pleural mesothelioma; the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Pleural Mesothelioma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemzar) (gemcitabine)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Malignant Mesothelioma | Phase 2 | Status: COMPLETED